ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

February 5, 1993

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980

NCAB Subcommittee Oks Concept Of Five Recompetitions

October 23, 1981

NCI’s Douglas Lowy and John Schiller Honored with National Medal

December 12, 2014

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011